Загрузка...
Metformin inhibits epithelial-mesenchymal transition of oral squamous cell carcinoma via the mTOR/HIF-1α/PKM2/STAT3 pathway
Epithelial-mesenchymal transition (EMT) serves an important role in the formation and development of various types of cancer, including oral squamous cell carcinoma (OSCC). Metformin, used for treating type 2 diabetes, has been revealed to exert an anticancer effect in various types of cancer, inclu...
Сохранить в:
| Опубликовано в: : | Oncol Lett |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
D.A. Spandidos
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7693125/ https://ncbi.nlm.nih.gov/pubmed/33262823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.12292 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|